Mineralys Therapeutics (MLYS)

Mineralys Therapeutics (MLYS) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• MLYS last traded at $15.52, -14.63% on the day.
• Mineralys Therapeutics: P/E -3.7.
• Over the past year MLYS returned -62.26%; year to date -57.23%.

Updated 2026-11-03 00:43 UTC